Is CRISPR Therapeutics a Millionaire Maker?
With a gene therapy for two illnesses out the door, and with sales slated to take off over the next few quarters, CRISPR Therapeutics (NASDAQ: CRSP) is making it a good time to be a shareholder.
But could this biotech's halcyon days be so good that a $10,000 investment today could end up being worth millions of dollars? Although such returns may seem wild, history is full of many such wealth-generating events. Let's dive in and explore if investors can bank on CRISPR Therapeutics stock to generate ground-breaking returns.
If CRISPR Therapeutics is going to experience dramatic growth, the road to becoming a millionaire will be called Casgevy.
Source Fool.com
